Novo Nordisk AS (NVO)
85.00
-18.44
(-17.83%)
USD |
NYSE |
Dec 20, 16:00
86.00
+1.00
(+1.18%)
After-Hours: 20:00
Novo Nordisk Total Assets (Quarterly): 59.53B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ascendis Pharma AS | 1.222B |
| Evaxion Biotech AS | 15.18M |
| Amgen Inc | 90.88B |
| Viking Therapeutics Inc | 937.89M |
| Akari Therapeutics PLC | 2.734M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 41.48B |
| Shareholders Equity (Quarterly) | 18.05B |
| Debt to Equity Ratio | 0.4727 |
| Current Ratio | 0.9367 |
| Net Debt Paydown Yield | -0.18% |